Levitra - 0173-0831-61 - (vardenafil hydrochloride)

Alphabetical Index


Drug Information of Levitra

Product NDC: 0173-0831
Proprietary Name: Levitra
Non Proprietary Name: vardenafil hydrochloride
Active Ingredient(s): 20    mg/1 & nbsp;   vardenafil hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Levitra

Product NDC: 0173-0831
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021400
Marketing Category: NDA
Start Marketing Date: 20030825

Package Information of Levitra

Package NDC: 0173-0831-61
Package Description: 1 BLISTER PACK in 1 CARTON (0173-0831-61) > 2 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of Levitra

NDC Code 0173-0831-61
Proprietary Name Levitra
Package Description 1 BLISTER PACK in 1 CARTON (0173-0831-61) > 2 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 0173-0831
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name vardenafil hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20030825
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name VARDENAFIL HYDROCHLORIDE TRIHYDRATE
Strength Number 20
Strength Unit mg/1
Pharmaceutical Classes Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]

Complete Information of Levitra


General Information